Sign in
Back
A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer
Journal article   Peer reviewed

A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer

JohnM Bennett, Patrick Byrne, Ajit Desai, Charles White, Ronald DeConti, Charles Vogel, Edward Krementz, Franco Muggia, James Doroshow, David Plotkin, …
Investigational new drugs, Vol.3(2), pp.179-185
1985
DOI: https://doi.org/10.1007/BF00174167
PMID: 3894279

Metrics

8 Record Views
16 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.219 Cancer Drugs
1.219.1342 Cardiotoxicity
Web Of Science research areas
Oncology
Pharmacology & Pharmacy
ESI research areas
Pharmacology & Toxicology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details